Urinary eosinophil-derived neurotoxin is associated with reduced lung function in pediatric asthma
- PMID: 38873905
- DOI: 10.1111/pai.14172
Urinary eosinophil-derived neurotoxin is associated with reduced lung function in pediatric asthma
Abstract
Introduction: Eosinophil-derived neurotoxin (EDN) is a biomarker for eosinophilic activation. Urinary (u) EDN may allow non-invasive monitoring of asthma, but clinical recommendations are lacking. We assessed the potential of uEDN as a marker of disease activity in pediatric asthma.
Methods: We assessed urine samples of 371 children from the German ALLIANCE study cohort, from which we had: 169 preschool wheezers (<6 years), 80 asthmatics (≥6 years), and 122 healthy controls using the ImmunoCAP™ EDN Assay. Creatinine (Cr)-adjusted uEDN values were analyzed using correlations, association tests, (non) parametric statistics, multiple linear, and multivariable regression.
Results: uEDN/uCr values were higher in atopic versus non-atopic preschool-aged subjects (p = .035) and associated with the sum of allergen-specific IgE in younger (r = 0.24, p = .003), and older subjects (r = 0.23, p = .043). uEDN/uCr was marginally a good determinant for atopy (p = .078, for subjects aged <6 years, and p = .058 for subjects ≥6 years). Children with the T2-high phenotype had higher uEDN/uCr (p < .001) versus T2-low-irrespective of using uEDN/uCr or blood eosinophils in combination to allergen sIgE for disease phenotyping. uEDN/uCr significantly correlated with reduced lung function among asthmatics (FEV1 z-scores: r = -0.30, p = .007, and FEV1/FVC z-scores: r = -0.24, p = .038). Using multivariable modeling, uEDN/uCr was an independent determinant of FEV1 (p = .038), and to a lesser extent, FEV1/FVC (p = .080).
Conclusions: uEDN/uCr may serve as a non-invasive biomarker for clinical features such as lung function in pediatric asthma. We highlight the utility of uEDN/uCr as a biomarker that can be easily assessed using widely available robust diagnostic immunoassays.
Keywords: T2‐high phenotype; atopy; biomarker; children; eosinophil‐derived neurotoxin; preschool wheeze.
© 2024 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
References
REFERENCES
-
- Asher MI, Garcia‐Marcos L, Pearce NE, Strachan DP. Trends in worldwide asthma prevalence. Eur Respir J. 2020;56(6):2002094. doi:10.1183/13993003.02094-2020
-
- Asher MI, Rutter CE, Bissell K, et al. Worldwide trends in the burden of asthma symptoms in school‐aged children: global asthma network phase I cross‐sectional study. Lancet. 2021;398(10311):1569‐1580. doi:10.1016/S0140-6736(21)01450-1
-
- Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and Overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198(8):1012‐1020. doi:10.1164/rccm.201804-0682CI
-
- Reddel HK, Bacharier LB, Bateman ED, et al. Global initiative for asthma strategy 2021: executive summary and rationale for key changes. Am J Respir Crit Care Med. 2022;205(1):17‐35. doi:10.1164/rccm.202109-2205PP
-
- Kim CK, Callaway Z, Park JS, Kwon E. Utility of serum eosinophil‐derived neurotoxin (EDN) measurement by ELISA in young children with asthma. Allergol Int. 2017;66(1):70‐74. doi:10.1016/j.alit.2016.05.008
MeSH terms
Substances
Grants and funding
- 197785619/CS is supported by the Universities Giessen and Marburg Lung Center (UGMLC), the German Center for Lung Research (DZL), University Hospital Giessen and Marburg (UKGM) research funding according to article 2, section 3 cooperation agreement, and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-SFB 1021
- 284237345/KFO 309
- 428518790/SK 317/1-1
- SCHA 997/9-1/German Research Foundation
- SCHA 997/10-1/German Research Foundation
LinkOut - more resources
Full Text Sources
Medical
